Eupraxia Pharmaceuticals (EPRX) Current Assets (2022 - 2026)
Eupraxia Pharmaceuticals (EPRX) recorded Current Assets of $136.8 million in the quarter ended Jun 30, 2026, up 499.2% from $22.83 million a year earlier but down 3.7% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Current Assets (2022 - 2026) Analysis & Trends
As of Dec 31, 2025, Eupraxia Pharmaceuticals reported Current Assets of $85.1 million, up 147.1% from the prior year.
- Annual Current Assets has increased for three straight years, with a three-year compound annual growth rate of 66.0% (years ended Dec 2022 to Dec 2025).
- Across earlier years, Current Assets came in at $34.44 million in the year ended Dec 31, 2024 (+73.9%), $19.8 million in the year ended Dec 31, 2023 (+6.5%) and $18.59 million in the year ended Dec 31, 2022.
- Quarterly Current Assets has ranged from $9.89 million in the quarter ended Sep 30, 2024 to $142.13 million in the quarter ended Mar 31, 2026 over the past five years.
- On a year-over-year basis, Current Assets has increased for four consecutive quarters, with growth averaging 273.3% over the last seven quarters.
- Peak year-over-year performance for Current Assets in the last five years was growth of 824.2% in the quarter ended Sep 30, 2025, against a decline of 21.0% in the quarter ended Mar 31, 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $142.13 million (quarter ended Mar 31, 2026), $85.1 million (quarter ended Dec 31, 2025) and $91.4 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Eupraxia Pharmaceuticals | 328.04 Mn | 326.44 Mn | - | 136.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 136.80 Mn |
| Mar 31, 2026 | 142.13 Mn |
| Dec 31, 2025 | 85.10 Mn |
| Sep 30, 2025 | 91.40 Mn |
| Jun 30, 2025 | 22.83 Mn |
| Mar 31, 2025 | 28.61 Mn |
| Dec 31, 2024 | 34.44 Mn |
| Sep 30, 2024 | 9.89 Mn |
| Jun 30, 2024 | 24.53 Mn |
| Mar 31, 2024 | 36.22 Mn |
| Dec 31, 2023 | 19.80 Mn |
| Dec 31, 2022 | 18.59 Mn |
API Access
Eupraxia Pharmaceuticals Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();